Is Genpact (G) Offering An Opportunity After Recent Share Price Weakness

• If you are wondering whether Genpact at around US$37.74 is a bargain or a value trap, the key is to understand what the current price actually reflects.
• The stock has moved 3.2% over the past week, while sitting on a 9.5% decline over 30 days and an 18.5% fall over the last year. These moves can change how the market views both its growth potential and risk profile.
• Recent coverage has focused on Genpact's positioning within professional services and how its business mix fits with longer term demand for outsourced operations and technology led services. Commentary has also highlighted how the company's profile compares with peers. That provides useful context for these share price moves even without new earnings updates.
• Simply Wall St currently gives Genpact a valuation score of 6 out of 6. The rest of this article will unpack how different valuation methods arrive at that result, before finishing with a broader way to think about what the market might be missing.

Genpact delivered -18.5% returns over the last year. See how this stacks up to the rest of the Professional Services industry.

Approach 1: Genpact Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a company might be worth by projecting its future cash flows and discounting them back to today’s value. It is essentially asking what Genpact’s future cash generation is worth in today’s dollars.

For Genpact, the model uses a 2 Stage Free Cash Flow to Equity approach based on its last twelve months free cash flow of about $730.4 million. Analyst estimates extend out to 2027, with projected free cash flow of $777.7 million in that year. Beyond that, Simply Wall St extrapolates cash flows through 2035, with annual projections between about $693.3 million and $1,166.8 million, all expressed in $ and discounted back to today using the model’s required return assumptions.

Adding these discounted cash flows together gives an estimated intrinsic value of $110.35 per share. Against the recent share price of about $37.74, this implies a 65.8% discount, which indicates that, under this cash flow based approach, Genpact is trading well below the estimated value.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Genpact is undervalued by 65.8%. Track this in your watchlist or portfolio, or discover 59 more high quality undervalued stocks.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Genpact.

Approach 2: Genpact Price vs Earnings

For profitable companies like Genpact, the P/E ratio is a practical way to think about value because it links what you pay directly to the earnings the business is already generating. In general, higher growth expectations and lower perceived risk tend to justify a higher “normal” P/E, while slower expected growth or higher risk usually line up with a lower multiple.

Genpact currently trades on a P/E of 11.60x. That sits below the Professional Services industry average P/E of 19.31x and below the peer group average of 22.20x, so the market is pricing Genpact’s earnings at a lower level than these broader benchmarks.

Simply Wall St’s Fair Ratio for Genpact is 20.16x. This is a proprietary estimate of what a reasonable P/E might be given Genpact’s earnings growth profile, industry, profit margins, market cap and risk factors. Because it blends these company specific drivers, the Fair Ratio can provide a more tailored anchor than a simple comparison with peers or the overall industry.

Comparing the Fair Ratio of 20.16x with the current P/E of 11.60x suggests the shares are trading below that indicated range.

Result: UNDERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your Genpact Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Narratives on Simply Wall St let you attach a clear story to your numbers by linking your view of Genpact’s business, its future revenue, earnings and margins to a forecast and then to a Fair Value that you can compare directly with the current price. Because Narratives on the Community page are updated as new earnings or news arrive, you can see, for example, one Genpact Narrative anchoring around the higher analyst target of US$58 and another around the lower US$42 target. This gives you two distinct stories and Fair Values to weigh against today’s share price when deciding whether it fits your own thesis.

Do you think there's more to the story for Genpact? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com